Company intelligence
Schrödinger
Transforming drug discovery and materials research
About Schrödinger
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com. Stay Alert: Avoid Recruitment Scams Across industries, cybercriminals are posing as company recruiters using fake job postings and employment offers. Please stay vigilant: - Never provide personal/financial information or payment to anyone claiming to offer a job opportunity - Always verify job postings through official company websites or direct contacts - Be cautious of unusual communication methods or overly quick offers
Verified activity
Signals from Schrödinger
6 published signals
Presence & Recognition
Schrödinger is attending the NPD Snackathon in London for Future Food-Tech on Sept 24 to discuss molecular physics and AI/ML in food and beverage R&D.
Reported by Schrödinger
Presence & Recognition
Schrödinger is hosting an EFMC Medicinal 2026 conference in Basel on Wednesday, September 9th, featuring a community meeting exploring agentic AI tools and the role of the medicinal chemist.
Reported by Schrödinger
People
Schrödinger's Structural Biology and Target Enablement team is growing to evaluate targets at the interface of computation and structure.
Reported by Ward G. Walkup IV, Ph.D.